Lexicon selects Medidata to advance Phase IIb non-opioid pain drug trial

Clinical Trials: The Ever-changing Face of Complexity

Clinical Trials Arena reports that Lexicon will work with Medidata to progress their Phase IIb of LX9211 study, leading to the first new drug to be approved for diabetic peripheral neuropathy in more than 20 years.